To address the molecular mechanism underlying the tumor suppressive functions of KLHL29 in TNBC, we conducted immunoprecipitation (IP) assays coupled with mass spectrometry (MS) analysis of potential KLHL29-interacting proteins in BT549 and CAL51 cell lines (Fig. 4A). The gene discussed is KLHL29; the disease is neoplasm.